dence, especially the truncated p values, reduce this problem. Conclusion: We identified regions modestly linked with type 2 diabetes by summarizing results from 23 autosomal genome scans.
Introduction
Linkage studies are widely used to map genetic variants that predispose to human diseases. However, for complex diseases like type 2 diabetes for which many genetic variants together with environmental and behavioral factors are likely involved [1] , mapping disease predisposing variants has proven to be difficult. To date, 1 20 genome wide linkage studies have been carried out to localize type 2 diabetes predisposing variants . In only a few cases have individual studies provided significant linkage results [2, 8, 12, 23] .
A likely explanation for these mixed results is that individual type 2 diabetes linkage studies are underpowered to detect predisposing variants with small effects. One approach to address this limitation is to carry out a joint analysis of the primary linkage data from a large number of studies. While a joint analysis of primary data is in principle an attractive approach to increase sample size and statistical power, it is not always possible to obtain data from all relevant studies. Differences in study populations, disease definition, and genetic markers genotyped also might lead to problems with this analytic approach. Therefore, meta-analysis of study results often is chosen as an alternative to joint analysis of the primary data to validate regions suggested by one or more smaller studies and to localize susceptibility variants suggested by weak but consistent evidence across multiple studies.
In this paper, we describe results of meta-analyses of 23 autosomal genome scans from the International Type 2 Diabetes Linkage Analysis Consortium (csg.sph.umich. edu/consortium/). This Consortium was formed to bring together groups around the world who are carrying out linkage studies of type 2 diabetes. Sixteen research groups have participated in the Consortium and have contributed autosomal genome scan data on a total of 23 samples. These studies provided an excellent basis for carrying out a large scale meta-analysis for type 2 diabetes.
We describe results for a genome scan meta-analysis (GSMA) [29] of the Consortium data. In GSMA, chromosomes are divided into bins of approximately equal length ( ϳ 30 cM), which are then ranked within each genome scan by their maximum linkage signal. The ranks are summed across genome scans at each bin to form the test statistics, with significance evaluated analytically or by permutation.
GSMA provides a simple means for combining data across multiple linkage studies. However, ϳ 30 cM bins provide only limited resolution, and ranking bins results in information loss, since the highest ranking bins may represent very different levels of linkage evidence across studies, and lower ranking bins likely provide limited and nearly equivalent linkage evidence within or across studies. Therefore, we also describe modifications of GSMA that address these limitations by considering more direct measures of linkage evidence and smaller bins, and report the results of these analyses on the Consortium data. Specifically, we repeat the meta-analysis using 2 cM rather than ϳ 30 cM bins, and use alternative scores for a bin's linkage evidence, including maximum bin LOD score and truncated minimum bin linkage p value. The latter is a modified version of Fisher's method [30] suggested by Zaykin et al. [31] . Since Fisher's method is known to have low power in the case in which many tests are not significant [32] , Zaykin et al. suggested that only p values less than some pre-chosen significance level be considered. This approach acknowledges that a broad range of p values are nearly equivalently uninformative, notably the approximate half of the genome for which the maximum LOD score is zero. Finally, we carry out computer simulations under null hypothesis of no linkage to compare the type I error rates of these alternative methods.
Materials and Methods

Samples and Sample-Specific Maps
We carried out meta-analysis on the results of autosomal linkage genome scans for 23 samples ( table 1 ) . Invitations were sent to all research groups known to be conducting genome-wide linkage studies of Type 2 diabetes, and the 23 samples are from the groups that agreed to participate. Detailed information about these samples is provided in the original references ( table 1 ) . These samples include a total of 9,455 affected individuals, and there is no known overlap between samples. For each sample, study investigators provided us with the marker maps (genetic markers and map positions in cM) used for the evaluation of linkage evidence, and files that gave LOD scores and corresponding chromosomal positions. LOD scores were evaluated at equally-spaced points along each chromosome (15 samples), or at each genetic marker position and at a fixed number of equally-spaced points between each marker pair (8 samples). There was substantial variability in genetic markers used and some variability in marker density across the 23 samples ( table 1 ) . Different groups used different statistical methods to evaluate the linkage evidence, including ASM LOD scores [33] , NPL LOD scores [34] , and variance component LOD scores [35] .
Map and LOD Score Conversion
All meta-analysis methods we applied assume that linkage results are reported for the same genetic map, or at least that marker maps are well aligned so that a bin corresponds to the same chromosomal region in each study. To minimize deviations from this assumption, we generated a single master genetic map based on the sex-averaged deCODE [36] and Marshfield [37] genetic maps using linear interpolation. For each marker M in a studyspecific map, we determined its position x on the master map according to the following procedures. First, if M was included in the deCODE map at position d , x = d . Second, if M was not in the deCODE map, but was in the Marshfield map at position m , we identified the nearest flanking markers for M which were in both the deCODE and Marshfield maps. If the flanking marker positions were d 1 ! d 2 and m 1 ! m 2 in the deCODE and Marshfield maps, respectively, then by linear interpolation,
. Third, if M was in neither the deCODE nor Marshfield maps, we used linear interpolation based on base pair distance in the August 2001 freeze of the Human Genome Project Working Draft [38] . 3,889 unique markers could be placed using this interpolation scheme; 96 markers could not be placed and were discarded.
We rescaled each study's LOD score evaluation positions in the same manner and calculated linear interpolated LOD score values at those evaluation positions. To obtain the interpolated LOD score L at position x, we found the two nearest flanking positions ( x 1 ! x ! x 2 ) at which LOD scores L 1 and L 2 were reported and calculated the interpolated LOD score as
. At chromosome ends, we used the LOD score at the nearest reported point on that chromosome. For each genome scan, we assigned ranks to bins by maximum linkage signal, so that the bin with the largest maximum linkage signal for that genome scan was assigned rank 115, the second highest rank 114, and so forth. To account partially for differences in study sample sizes, we calculated the score for bin b as
, where w i is the square root of number of affected individuals in study i and R i ( b ) is the rank of bin b in study i . To estimate the significance for a particular bin score S( b ), we used a permutation approach. Specifically, we generated a large number of replicate permutations of the ranks of bins within each study, recalculated the scores S( b ) over all bins b in the genome, and pooled these scores over all permutations and bins to estimate the distribution of S( b ). For a bin b with observed score S( b ), we estimated its p value as the proportion of observed S( b ) values greater than or equal to the observed S( b ).
Linkage Meta-Analysis Methods: Alternative Scoring Schemes
To reflect the strength of linkage results more directly, we considered two scoring schemes as alternatives to weighted ranks. ( table 1 ) all have the same asymptotic distribution under the null hypothesis (1/2 : 1/2 mixture of 2 distribution with 1 degree of freedom and point mass at 0, divided by 2 ln10 [39] ), we were able to combine the reported LOD scores directly from individual studies. Had this not been the case, transformation would have been required to put the linkage statistics on a common scale.
Second, we calculated the minimum p values of bins,
is the cumulative chisquare distribution with 1 degree of freedom. We then truncated the minimum p values bins at 0.05
Truncating p values in this way meant that any p 1 0.05 was treated as equally uninformative.
We evaluated the significance of these two scores by permutation as described above for ranks.
Linkage Meta-Analysis Methods: Bin Width
To obtain higher resolution than that provided by ϳ 30 cM bins, we repeated all three meta-analysis methods using bins of width 2 cM, yielding 1,758 bins for the autosomal genome ( table 2 ).
Subgroup Meta-Analysis
We carried out subgroup analyses on subsets of studies defined by the historical geographic ancestry of their samples. We did so for European/European American, African/African American, and Mexican American ( table 1 ) .
Simulation
To compare the meta-analysis methods, we obtained family structures, genotypes, marker maps, and marker allele frequencies for each genome scan from each of the participating research groups. We then used gene dropping to evaluate the validity of the six combinations of three scoring schemes and two bin widths, and to evaluate the impact of differing sets of markers used in the different studies and uneven marker densities within each study.
We simulated pedigree data for the 23 studies under the null hypothesis of no linkage using MERLIN version 0.10.3 [40] . To reduce the computation load, we reduced the complexity of some family sets. Specifically, we restricted samples to nuclear families, and deleted unaffected siblings as needed so that no nuclear family had 1 8 siblings. The numbers of individuals used in the simulations for each of the 23 studies are listed in table 1 . We considered three simulation conditions. In simulation 1, to evaluate the type I error rates in our meta-analysis, we generated genotype data for each study based on the marker map for that study. In simulation 2, we generated genotype data for all 23 studies based on the marker map for one study (FUSION 1 [11] ) to eliminate the difference between individual studies. In simulation 3, we generated genotype data for all 23 studies based on an artificial map in which each autosome is 150 cM long, markers are evenly spaced at 10 cM, and each marker has four equally-frequent alleles. Compared to results in simulation 2, simulation 3 allows us to further assess the impact of (uneven) marker density and informativeness on type I error rates. For each of the three simulation settings, we generated 1,000 simulated datasets, each comprised of 23 samples, as in the Consortium study. We carried out affected sibling pairs (ASP) linkage analysis with LOD scores evaluated every 2 cM based on the linear model of Kong and Cox [33] using MERLIN, version 0.10.3 [40] . We carried out meta-analysis for each of our statistics computed for ϳ 30 and 2 cM bins, and estimated significance levels (P i ) by permutation using 1,000 permutation iterates per simulated dataset. We estimated the empirical p values for each bin as the proportion of the P i 's less than 0.05 at the corresponding bin for the 1,000 simulation replicates.
Results
Meta-Analysis of Consortium Data
We first carried out meta-analyses using ϳ 30 cM bins. In this analysis, two regions showed significant results at the 0.01 level: chromosome 10 at 119-148 cM (p TP = 0.0020) and chromosome 14 at 31-62 cM (p LOD = 0.0051, p TP = 0.0068). All positions here and later are in the de-CODE map. Although the signals did not meet genomewide significance, they did meet genome-wide suggestive significance, that is, one false positive per genome scan, based on Bonferroni correction. Interestingly, the chromosome 10 region includes the transcription factor 7-like 2 ( TCF7L2 ) gene [41] , variants in which are known to influence type 2 diabetes susceptibility.
We next performed the meta-analyses for 2 cM bins to obtain finer resolution ( table 3 , fig. 1 ). Consistent with the 30 cM bin analyses, the strongest results for the combined data for the LOD score (p LOD ) and truncated p value (p TP ) based analyses were obtained on chromosome 14 at ϳ 58 cM (p LOD = 0.0011, p TP = 0.0017), chromosome 10 at ϳ 138 cM (p LOD = 0.0021, p TP = 0.0019), about 4 cM from TCF7L2 . Other interesting results were obtained on chromosome 4 at ϳ 76 cM (p LOD = 0.0048, p TP = 0.0055) and ϳ 176 cM (p LOD = 0.0129, p TP = 0.0074), but these do not meet the genome-wide suggestive significance based on the Bonferroni correction. All these regions also were identified as being of interest in the weighted rank-based analysis (p RANK ! 0.10), with the chromosome 10 region the second strongest rank-based result (p RANK = 0.0055). Table 4 lists the studies that made notable contributions (LOD 1 1.0) to each of these meta-analysis linkage signals. Notably, the chromosome 2 signal at 258 cM is 1-2 cM from calpain-10 [42] . Also, the chromosome 3 signal at ϳ 60 cM is ϳ 20 cM from the peroxisome proliferator-activated receptor gamma ( PPARG [43] ) locus.
Combining results over all studies implicitly assumes that genetic mechanisms and allele frequencies are consistent across all groups. In an attempt to decrease genetic heterogeneity, we re-ran the analysis on geographically defined subgroups: European/European American, African/African American, and Mexican American ( table 1 ). The regions identified by at least one method (LOD score, truncated p value, and/or rank) using ϳ 30 cM bins (significant at the 0.01 level) are listed in table 5 . Many of these regions identified by subgroup analyses were not identified in the full analyses, consistent with either more power with more homogeneous subsets of the data, or an increased false positive rate owing to more tests. Among The results are presented separately for different scoring schemes: weighted ranks (Rank w ); maximum LOD score (LOD); truncated minimum p value (TPM). The best p values within these regions are given in parentheses. 
Simulation Results: Type I Error
To assess the validity of the different meta-analysis methods, we carried out a computer simulation. Results are summarized for each meta-analysis score and bin width ( table 6 ). The bin-wise type I errors are calculated as the proportions of simulation replicates with p value ! 0.05, and are then averaged over all bins on the genome. Given study-specific maps with different marker densities (simulation 1) and ϳ 30 cM bins, the average type I error rates are modestly inflated beyond the nominal 0.05 level, but the point-wise type I errors can be either inflated or deflated, resulting in fairly large variations among bins. Inflation and variation are greatest for ranks and least for truncated p values, and greater for ϳ 30 cM bins than for 2 cM bins. Given a constant map across all studies (simulation 2), inflation of the average type I error rates and the variations are reduced, particularly for 2 cM bins. The truncated p value based method still outperforms the other two in both average type I error rates and variation. The inflation is eliminated for 2 cM bins and the variations are greatly reduced for all the methods, comparable to those obtained in simulation 3. Given the artificial setting of identical length chromosomes and identical marker maps across studies (simulation 3), type I error rates are consistent with nominal levels for all methods. Similar results were obtained evaluated for genome-wide suggestive type I error rates.
While simulation 1 tries to reproduce the scenario of our meta-analyses of the consortium data, simulation 2 unifies the sets of markers used in different studies. Because the simulations were carried out under the null hypothesis of no linkage, the positions of markers should not affect the linkage or meta-analysis results. Difference in marker sets in fact reflects the variation of marker distributions across studies, and then impacts the results through effect of marker densities. Elimination of this difference gives us a better opportunity to evaluate the The results are presented separately for different scoring schemes: weighted ranks (Rank w ); maximum LOD score (LOD); truncated minimum p value (TPM). a Bin-wise significance level is .05. b Genome-wide suggestive significance levels are 1/(number of bins) using the Bonferroni correction, which are 0.87 ! 10 -2 (setting 1 and 2) and 0.91 ! 10 -2 (setting 3) for 30-cM bins, and 0.57 ! 10 -3 (setting 1 and 2) and 0.60 ! 10 -3 (setting 3) for 2-cM bins. effect of uneven marker densities. As an example, the results of simulation 2 using 30 cM bins (and truncated p values as the test statistics) are shown in figure 2 . The graph shows that several bins on chromosome 6, 11, 12, and 20 have inflated type I error rates 1 0.10, and the two bins on chromosome 22 have empirical type I error rates ! 0.02. This observation corresponds to the unusually high or low marker densities on the five chromosomes. The average marker distances on chromosomes 6, 11, 12, 20, and 22 are 5.3, 5.9, 5.9, 3.9, and 22.6 cM, respectively, compared to 8.5 to 11.7 cM on other chromosomes, suggesting that bins with higher marker densities tend to produce larger test statistics and more false-positive results. In contrast, for the 2 cM bins, the p values in these regions vary between 0.030 and 0.073, with most values close to the nominal value of 0.05. In simulation 3, when the markers are evenly spaced on the genome, inflation of the average type I errors disappears and variation is substantially reduced. This suggests that uneven marker spacing may play a role in departures of type I errors from nominal levels. Furthermore, the somewhat better performance of 2 cM compared to ϳ 30 cM bins may reflect a dilution of the effect of uneven marker density by the increased number of bins.
In simulation 1, the four regions (chromosome 4 at ϳ 76 cM and at ϳ 176 cM, 10 at ϳ 138 cM, and 14 at ϳ 58 cM) identified in the meta-analyses have acceptable empirical type I errors between 0.037 and 0.086 for all the three methods when using 2 cM bins ( table 7 ) . These results suggest that linkage evidence may be modestly overstated on chromosomes 4 ( ϳ 76 cM) and 14 ( ϳ 76 and ϳ 176 cM), and modestly understated on chromosome 10 ( ϳ 138 cM).
Discussion
This meta-analysis of all 23 type 2 diabetes autosomal genome scans provides modest evidence for linkage on several chromosomes, notably 14 ( ϳ 58 cM in the de-CODE map), 10 ( ϳ 138 cM), 4 ( ϳ 76 cM and ϳ 176 cM), and 16 ( ϳ 44 cM). When we restricted our attention to geographically/racially defined subgroups in an effort to decrease genetic heterogeneity, we found evidence for several additional chromosomal regions, notably chromosomes 1 ( ϳ 164 cM in Europeans/European Americans, and ϳ 144 cM in Africans/African Americans), 2 ( ϳ 246-258 cM in Mexican Americans), and 6 ( ϳ 116 cM in Europeans/European Americans, and ϳ 152 cM in Africans/African Americans). Many of these regions are only identified in one subgroup and so may reflect true etiologic differences by group or a combination of false positives and false negatives.
Two regions which have received considerable attention in the type 2 diabetes genetic linkage literature owing to repeated reports of genetic linkage are 1q [beginning with 5, 8 ] and 20q [beginning with 4, 44, 45 ] . While neither of these regions was among the most interesting in this meta-analysis, both yielded some evidence for linkage: for chromosome 1 at ϳ 166 cM, p TP = 0.013, and for chromosome 20 at ϳ 62 cM, p TP = 0.071 and p LOD = 0.039. In subgroup analyses on European/European American samples both regions are significant at the 0.01 level, but are not interesting in African/African American or Mexican American samples (all p 1 0.10). The results are presented separately for using different scoring schemes: weighted ranks (Rank w ); maximum LOD score (LOD); truncated minimum p value (TPM).
Several genome-wide association studies [46] [47] [48] [49] [50] [51] have recently been published on susceptibility loci for type 2 diabetes. Except the TCF7L2 gene which is identified by all the six studies and is one of the strongest signals in our meta-analysis, the other main signals found in these association studies are not close to the signals in meta-analysis. But there are intriguing overlaps between some modestly associated single nucleotide polymorphisms (SNPs) and our meta-analysis peaks. For example, our signal on chromosome 4 ( ϳ 76 cM) is ϳ 1 Mb from SNP rs282705 reported by Sladek et al. [46] (p = 9.0 ! 10 -6 ), and 5 Mb from SNP SNP_A-4299379 reported by Saxena et al. [48] (p = 7.2 ! 10 -5 ). Our signal on chromosome 14 ( ϳ 58 cM) is ϳ 8 Mb from SNPs rs1256517 and rs1256526 in Sladek et al. [46] (p = 4.7 ! 10 -6 ). Our signal on chromosome 16 ( ϳ 44 cM) is ϳ 1 Mb from a modestly associated SNP rs724466 in Steinthorsdottir et al. [50] (p = 2.7 ! 10 -5
), and ϳ 8 Mb from one of a modestly associated SNP rs10521095 in Scott et al. [47] (p = 3.8 ! 10 -5 ).
Demenais et al. [52] conducted a meta-analysis of four type 2 diabetes linkage scans of European samples using the GSMA method with unweighted ranks. These four studies: University of Lund Botnia, University of Lund Sibs, United Kingdom, and Pasteur Institute Lille, are included in our analyses, although with slight differences in the samples. Demenais et al. found six regions on the genome to be nominally significant at 0.05 level. Their region on chromosome 16 (29-58 cM) directly overlaps one of our top four signals (chromosome 16 ϳ 44 cM). Four more of their regions on chromosomes 1 (145-174 cM), 2 (58-87 cM), 6 (116-145 cM), and 17 (29-58 cM) are also at least nominally significant at the 0.05 level in our analyses ( table 3 ) , and the chromosome 1, 16, and 17 regions also are significant at the 0.01 level in our subgroup analyses of 11 European/European American samples ( table 5 ) .
While these results are of interest, it should be noted that the evidence for linkage at individual locations and overall is at best modest. For the ϳ 30 cM bins, the smallest p values for the truncated p value, LOD score, and weighted rank methods were 0.0020, 0.0051, and 0.0138, respectively. None of these p values met the threshold for genome-wide significance using the Bonferroni correction. Indeed, among 115 tests based on the ϳ 30 cM bins, 2 were significant at the 0.01 level and 3 at the 0.05 level for the truncated p value method; 1 and 6 for the analyses based on LOD scores, and 0 and 9 for those based on weighted ranks. 1.15 and 5.75 such results would be expected at the 0.01 and 0.05 levels in the absence of linkage information. Similarly, the minimum p value observed for 2 cM bins for the truncated p value based meta-analysis was 0.0017, while those for the LOD score and weighted rank based analyses were 0.0011 and 0.0020. Among 1,758 tests based on the 2 cM bins, 18 were significant at the 0.01 level and 94 at the 0.05 level for the truncated p value method; these numbers were 18 and 83 for the analyses based on LOD scores and 8 and 90 for those based on weighted ranks. 17.58 and 87.90 such results would be expected at the 0.01 and 0.05 levels even in the absence of linkage information. Again, no excess of small p values was observed.
The GSMA method proposed by Wise et al. [29] provides an approach to combine the results of multiple linkage studies to identify susceptibility loci for the disease of interest. It suggests the use of ranks to unify various measures of linkage results and the use of bins ( ϳ 30 cM) to obtain independence of test statistics. Our simulations have shown that GSMA results in appropriate type I error rates under the conditions of homogeneous marker sets and constant marker density (simulation 3), but results in modestly inflated type I error rates on average and some variability in these rates by location under more realistic settings (simulations 1 and 2). The alternative scoring schemes of maximum LOD scores and truncated p values provided similar but slightly better type I error control. The truncated p value method not only gives the best average type I error rate compared to the nominal value, but also the smallest standard deviations among the methods using the three scores ( table 6 ) .
Ranks allow the advantage of easy conversion of different types of linkage scores (such as LOD scores, mean IBD sharing, or p values) into a uniform scale, but do not directly reflect the strength of the corresponding linkage signals. Even under the null hypothesis of no linkage anywhere in the genome, high ranks still must be assigned and often will be assigned to regions with little evidence for linkage. Since most linkage studies report statistics that are of (approximately) known asymptotic distribution, conversion to a common scale such as LOD scores or p values should usually be possible, as was the case for the 23 samples in the Consortium data.
Analysis based on LOD scores preserves the magnitude of the linkage results from each study. Analysis based on truncated p values emphasizes the gap between 'significant' (smaller than a cut-off value) and 'insignificant' (greater than a cut-off value) results by replacing the latter by the extreme value of 1. Both methods make use of more information than the ranks. In addition, since the bins falling into the same linkage peak are obviously correlated, the truncated p value based analysis narrows the width of the peak by truncating 'insignificant' results into the baseline and hence reduces the extent of correlation among the test statistics. This may explain the better control of the type I error rates using this method. Forabosco et al. [53] showed that only using strongly significant results, such as LOD score 1 1, 2, or 3, will result in loss of power in GSMA. In our analyses, we use the more modest threshold value of 0.05 for the p values, which corresponds to a LOD score of 0.59. We also conducted the meta-analyses using a cut-off p value of 0.10 (results not shown), and the results are similar to those presented here with no additional interesting regions identified. Our analyses results from using the LOD scores (and so no p value truncation) and truncated p values are also highly correlated, with Pearson correlation of 0.88 between the logarithm of the p values.
We also carried out meta-analyses and simulations using ranks without weighting by sample size and minimum p values without truncation as measures of linkage signals (results not presented). Unweighted ranks are expected to perform less well than the other methods since they ignore differences in the amount of information contained in individual studies. (Non-truncated) minimum p values produced results highly correlated with those using the maximum LOD scores, with the Pearson correlations 0.96 and 0.92 in ϳ 30 cM and 2 cM bin methods respectively, and identified three out of the four best regions; the region ϳ 76 cM on chromosome 4 was not identified at 0.05 significance level by this method.
Besides considering alternative scoring schemes, we also considered narrower bin widths. Although ϳ 30 cM bins can contain some linkage peaks and potentially reduce the correlation between adjacent bins, it is still difficult to develop a good binning approach to keep all linkage peaks from being split into two or more bins. Further, wide bins decrease the resolution of the linkage results, and may attenuate the distinction between weaker and stronger linkage signals. We therefore decided to use 2 cM bins as an approximation of continuous evaluation of the linkage statistic. An advantage of the narrow bins is that most of the bins contain zero or one markers in the linkage studies we collected. The effect of marker densities is likely minimized, consistent with the better control of type I errors using narrower bins in simulations 1 and 2.
Since LOD scores were not calculated at every 2 cM in every study, we interpolated the LOD scores linearly (see 'Materials and Methods'). To evaluate the impact of interpolation, we calculated the LOD scores at every 10 cM instead, using the same simulated pedigrees and genotypes as those in our simulations, and interpolated the scores at every 2 cM. The interpolated scores are very close to the actual values and should not have changed the power of GSMA noticeably.
Because the test statistics (ranks, LOD scores, or truncated p values) are permuted within study to assess the significances, splitting a linkage peak into multiple bins, which we shall call correlated bins, causes dependence of bins and may bias the estimated p values from permutation. Using 2 cM bins obviously does increase the number of correlated bins. However, and more important, it does not change the proportion of correlated bins compared to that using ϳ 30 cM bins. For example, we simulated 100 chromosomes of 150 cM under the null hypothesis, and counted the number of bins belonging to the same linkage peak; here a peak is defined as the contiguous bins with LOD 1 0. The proportion of correlated bins was 0.429 for 2 cM bins, and 0.508 for 30 cM bins. For the truncated p values with cut-off at 0.05, that is, LOD 1 0.59, the proportions dropped to 0.043 and 0.058 for 2 cM and 30 cM bins, respec tively.
A more important issue with 2 cM bins is the problem of multiple testing. With more bins, a substantially more stringent threshold for p values will be required to declare genome-wide significance of any bin. On the other hand, the 2 cM bins do provide higher resolution for the interesting regions, which can be more easily compared with other linkage studies and genome-wide association studies. The 2 cM bin-based methods also control the type I error rates better than the ϳ 30 cM-based methods, especially when there is substantial variability in marker density. Therefore, we suggest an initial screening using ϳ 30 cM bins followed by using 2 cM bins to localize linkage signals and control for false positives.
To obtain more accurate evaluation of significance, we may need to know the multi-dimensional distributions of the test statistics under the same settings of our meta-analyses of the Consortium data. Ideally, if we could use the complete pedigree information in simulation 1 without the pedigree reduction described in 'Materials and Methods', it would provide an estimate for the desired distribution, given that the number of simulation replicates is sufficiently large. A similar approach was suggested by Wise [54] to combine candidate region studies with genome-wide studies using the GSMA method. If we are willing to ignore the differences between the Consortium data and the reduced data for simulation, we can estimate the p value of each bin as the proportion of simulation replicates in which the score of the bin in simulation was greater than that in our meta-analyses. The same regions were then identified on chromosome 10 and 14 using either ϳ 30 cM bins or 2 cM bins, and on chromosome 4 using 2 cM bins at the 0.01 significance level, with p values similar to those obtained by permutations.
When data are available, a joint linkage analysis may also be performed by pooling pedigree information across the same 23 individual studies. Its results should be similar to ours from the meta-analyses described here, but some differences can also be expected. The meta-analysis considers only positive linkage signals, while in the joint analysis, deficiencies of sharing in some studies may cancel excess sharing in other studies. In the meta-analysis, individual studies can apply various methods of analysis, including parametric/non-parametric and variance component linkage analyses, and might consider auxiliary phenotype data. Although this flexibility is appreciated when original genotype data cannot be accessed, it may add heterogeneity among the individual studies' results to be summarized by the meta-analysis. On the other hand, while the joint analyses can make a better use of information, they are sometimes limited by computational powers needed for the large sample size of the pooled sample.
In summary, our meta-analyses of the International Type 2 Diabetes Linkage Analysis Consortium data suggested evidence for linkage on regions of chromosomes 4, 10, 14, and 16 for type 2 diabetes, with no signal reaching genome-wide significance, but those on chromosomes 10 and 14 reaching a level expected to occur by chance once per genome. Subgroup analyses are consistent with the possibility that genetic heterogeneity of the collected samples may be a cause for the modest linkage signals. Computer simulations showed that variations of the marker density within and between studies could result in modestly inflated or deflated type I errors in current analyses. Smaller bins (2 cM) and alternative test statistics more directly based on the linkage evidence, such as LOD scores or truncated p values, may help to draw the type I errors towards the nominal value, but more sophisticated approaches need to be considered to correct this problem fully.
